Institutional Ownership Sc Pharmaceuticals Inc. (SCPH)
This table provides information about the institutional ownership of Sc Pharmaceuticals Inc. (SCPH). We have compiled data on the 87 institutions that hold shares in the stock, with a total of 39.1 Million shares, which have been reported (via 13F filing form) to have a value of $131 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Orbimed Advisors LLC
San Diego, CA |
Feb 14, 2025 Q4 2024 |
6,059,528
shares
|
$20.4 Million
0.58% of portfolio
|
Q3 2024
Added 8.99%
|
|
Rubric Capital Management LP
New York, NY |
Feb 14, 2025 Q4 2024 |
4,775,000
shares
|
$16 Million
0.28% of portfolio
|
Q3 2024
Added 35.46%
|
|
Aigh Capital Management LLC
Baltimore, MD |
Feb 12, 2025 Q4 2024 |
4,174,367
shares
|
$14 Million
5.98% of portfolio
|
Q4 2024
Added 1.21%
|
|
King Luther Capital Management Corp
Fort Worth, TX |
Feb 07, 2025 Q4 2024 |
2,857,910
shares
|
$9.6 Million
0.04% of portfolio
|
Q4 2024
Added 28.4%
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
2,108,457
shares
|
$7.08 Million
0.0% of portfolio
|
Q4 2024
Added 23.38%
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
1,910,088
shares
|
$6.42 Million
0.0% of portfolio
|
Q4 2024
Added 474.2%
|
|
Suvretta Capital Management, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
1,840,891
shares
|
$6.19 Million
0.27% of portfolio
|
Q4 2024
Reduced 10.16%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
1,768,669
shares
|
$5.94 Million
0.0% of portfolio
|
Q2 2024
Reduced 1.83%
|
|
J. Goldman & CO LP
New York, NY |
Feb 14, 2025 Q4 2024 |
1,219,127
shares
|
$4.1 Million
0.12% of portfolio
|
Q4 2024
Reduced 11.66%
|
|
5 Am Venture Management, LLC
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
1,200,647
shares
|
$4.03 Million
1.89% of portfolio
|
Q1 2023
Reduced 56.1%
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
1,037,279
shares
|
$3.49 Million
0.0% of portfolio
|
Q4 2024
Added 5218.29%
|
|
Thrivent Financial For Lutherans
Minneapolis, MN |
Feb 10, 2025 Q4 2024 |
1,036,665
shares
|
$3.48 Million
0.01% of portfolio
|
Q4 2024
Reduced 1.17%
|
|
Nantahala Capital Management, LLC
New Canaan, CT |
Feb 14, 2025 Q4 2024 |
1,000,000
shares
|
$3.36 Million
0.18% of portfolio
|
Q4 2024
Added 33.33%
|
|
Rice Hall James & Associates, LLC
|
Jan 31, 2025 Q4 2024 |
989,635
shares
|
$3.33 Million
0.21% of portfolio
|
Q4 2024
Added 59.19%
|
|
Kingdon Capital Management, L.L.C.
New York, NY |
Feb 14, 2025 Q4 2024 |
800,000
shares
|
$2.69 Million
0.46% of portfolio
|
Q3 2024
New holding
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
750,493
shares
|
$2.52 Million
0.0% of portfolio
|
Q4 2024
Added 16.66%
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
725,055
shares
|
$2.44 Million
0.0% of portfolio
|
Q4 2024
Added 6.29%
|
|
Stonepine Capital Management, LLC
Bend, OR |
Feb 13, 2025 Q4 2024 |
683,530
shares
|
$2.3 Million
1.95% of portfolio
|
Q4 2024
Reduced 12.24%
|
|
Tejara Capital LTD
London, X0 |
Feb 10, 2025 Q4 2024 |
612,850
shares
|
$2.06 Million
1.42% of portfolio
|
Q4 2024
Reduced 5.75%
|
|
Perceptive Advisors LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
500,000
shares
|
$1.68 Million
0.06% of portfolio
|
Q4 2024
New holding
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
409,460
shares
|
$1.38 Million
0.0% of portfolio
|
Q4 2024
Added 447.63%
|
|
Apis Capital Advisors, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
394,000
shares
|
$1.32 Million
1.53% of portfolio
|
Q4 2024
Added 146.25%
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
324,226
shares
|
$1.09 Million
0.0% of portfolio
|
Q4 2024
Added 27.08%
|
|
Woodline Partners LP
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
297,800
shares
|
$1 Million
0.01% of portfolio
|
Q4 2024
Reduced 40.63%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Feb 14, 2025 Q4 2024 |
109,909
shares
|
$369,294
0.0% of portfolio
|
Q4 2024
Reduced 22.13%
|